NCT06027086
- Conditions
- Carcinoma, Fibrolamellar Hepatocellular Carcinoma, Fibrolamellar hepatocellular carcinoma, +3 more
- Locations
-
- Johns Hopkins SKCCC Baltimore, Maryland, United States
Clinical trial condition
Fibrolamellar Hepatocellular Carcinoma
Explore clinical trials studying Fibrolamellar Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
2 recruiting studies
Fibrolamellar Hepatocellular Carcinoma trial results
Recruiting
FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition
NCT05937295
- Conditions
- Fibrolamellar Hepatocellular Carcinoma, Fibrolamellar hepatocellular carcinoma
- Locations
-
- University Hospital Tuebingen Tübingen, Baden-Würtemberg, Germany